🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chronic Migraine

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine NCT06974617NA1 site📍 Cairo Cairo University · Tests: Sphenopalatine block, Botulinum Toxin Type A Cannabis for the Prophylactic Treatment of Migraine NCT03972124Phase 21 site📍 Calgary University of Calgary · Tests: CBD 100 mg OD, CBD 200 mg OD, Placebo Dietary Intervention for Migraine Relief NCT07360405NA1 site📍 Washington D.C. American University · Tests: Dietary training i-NEED: NEw migrainE Drugs Database NCT07103694n/a2 sites📍 Milan📍 Rome IRCCS San Raffaele Roma · Tests: anti-CGRP monoclonal antibodies, gepants, combination of sumatriptan and naproxen, ditan Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine NCT07159750n/a26 sites📍 Miami📍 Buenos Aires📍 Santiago Hospital Universitari Vall d'Hebron Research Institute · Tests: CGRP antibody or gepant Gepant treAtments: EffectIveNess and tolERability (GAINER) NCT05903027n/a2 sites📍 Florence📍 Pavia University of Florence · Tests: Rimegepant 75 MG Disintegrating Oral Tablet A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine NCT04965675Phase 379 sites📍 New Haven📍 Stamford📍 Washington D.C. H. Lundbeck A/S · Tests: Eptinezumab, Placebo EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine NCT07652034n/a1 site📍 Tacoma Cortex Neurovascular · Tests: Middle Meningeal Artery Embolization Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult NCT06322407NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Stellate Ganglion Block (SGB), standardized drug treatment Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial NCT05337033Phase 23 sites📍 Vancouver📍 Halifax📍 Toronto University of Manitoba · Tests: MPL-001 The Neuroanatomical and Psychological Correlates of Suggestibility in Patients With Non-Responsive Chronic Migraine NCT07617441n/a1 site📍 Catanzaro Istituto per la Ricerca e l'Innovazione Biomedica A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years NCT06810505Phase 366 sites📍 Huntsville📍 Fayetteville📍 Little Rock AbbVie · Tests: Atogepant, Placebo for Atogepant Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache NCT07347730NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: MTrPs injection, C2 dorsal root ganglion blocks Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) NCT07347041NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Joint Cavity Injection, MTrPs Injection Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine NCT06603558n/a36 sites📍 Busan📍 Busan📍 Busan AbbVie · Tests: Atogepant Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification NCT06674772n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Saliva test Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Migraines and Tension Type Headache NCT06921109NA1 site📍 Sart Tilman University of Liege · Tests: Experimental: Relaxation training with VR, Experimental: Relaxation training without VR, No Intervention: Control group CGRP Inhibition, Autonomic Function, and Migraine NCT04628429n/a1 site📍 Vienna Medical University of Vienna · Tests: Erenumab, Galcanezumab, Fremanezumab Determining the Utility of a Behavioral Intervention in Chronic Migraine NCT05415020NA1 site📍 Phoenix Mayo Clinic · Tests: Lifestyle Behavior Protocol, Sham Behavior Protocol EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. NCT05570149n/a1 site📍 Roma IRCCS San Raffaele Roma · Tests: Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution Relieving Chronic Pain: Psychosomatic Mechanisms and Psychological Interventions in Fibromyalgia and Chronic Headache NCT06652724NA2 sites📍 Rome📍 Rome University of Roma La Sapienza · Tests: Dynamic interpersonal therapy (DIT), technique of expressive writing (TSE), Treatment as Usual (TAU) Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA) NCT07347054NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Joint Cavity Injection, MTrPs Injection Mind Body Intervention for Chronic Migraine Headaches NCT06690060NA2 sites📍 Boston📍 Boston Beth Israel Deaconess Medical Center · Tests: Mind-Body Intervention CHROnic Migraine Embolization NCT06848166NA1 site📍 Bishkek Vedanta University Clinic · Tests: liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine NCT07571889NA1 site📍 East Providence Association of Migraine Disorders · Tests: onabotulinumtoxinA prophylaxis with Lidocaine, OnabotulinumtoxinA prophylaxis with Saline Supraspinal Processing of Sensory Aspects of Pain NCT05814497NA1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Multisensory Task, Graphesthesia, Divided attention Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics NCT03231241n/a1 site📍 Stanford Stanford University New Methods for Evaluating Preventive Migraine Treatment NCT07071506NA2 sites📍 Aarhus C📍 Aarhus N University of Aarhus · Tests: Active drug for chronic migraine treatment., Placebo Subcutaneous injection A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine NCT05164172Phase 364 sites📍 New Haven📍 Stamford📍 Gainesville H. Lundbeck A/S · Tests: Eptinezumab Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy